News

Fierce Biotech2h
MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b
Mean body weight reductions after 24 weeks ranged from 8.2% to 10.3% in the MDR-001 cohorts, versus 2.5% in the placebo arm.
MedPage Today on MSN1d
Novel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly Dosing
An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with ...
Experimental drug helps patients lose nearly a quarter of body weight in early trials
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
STAT19h
GLP-1 drug helped type 1 diabetes patients keep healthy glucose levels and lose weight
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...
Which is more effective for weight loss, GLP-1 drugs or surgery? New study has answer
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds
Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...
Weight-loss jabs ‘could be hitting supermarket food sales’ as 4% of households now take them
The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...
BenefitsPRO31m
More than 90% of GLP-1 prescriptions could be filled at lower cost, analysis finds
A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly 33 million Americans currently taking GLP-1 medications monthly, indicates a potential ...